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Conclusions: DIBH lowered the estimated dose to heart and 
lung while IMRT increased the mean breast dose regardless of 
breathing technique. In average, LYL was lowest with DIBH 
and highest with FB. Overall in this cohort, 3D-DIBH resulted 
in the lowest estimated doses life-time excess risks, though 
combining IMRT and DIBH could be beneficial for a sub-group 
of patients. 
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Purpose/Objective: Tumour control probability (TCP) models 
may be useful for evaluation and optimisation of 
radiotherapy (RT), in particular in dose escalation/painting 
strategies. Most TCP models apply homogeneous values of the 
involved parameters such as the initial tumour cell density or 
the involved radiobiological parameters. However, functional 
imaging techniques may provide patient-specific information 
that could be taken advantage of in TCP modelling. Focusing 
on RT of prostate cancer, the aim of this study was to 
develop a method for individualising TCP models based on 
tumour cell density distributions estimated from magnetic 
resonance imaging-based apparent diffusion coefficient (ADC) 
maps. 
Materials and Methods: The TCP models were based on 
linear-quadratic cell survival curves, while also including 
terms such as treatment time (i.e. repopulation, with an 
effective doubling time of 28 days), cell repair (with a repair 
half time of 5 h) as well as a variation of the radiobiological 
parameters between sub-populations (SD of α and β of 15%). 
Using ADC maps in a series of 10 prostate cancer patients, 
the initial number of clonogens in each voxel (N0,i = ri·Vvoxel) 
was estimated using two different approaches for the 
relation between ADC values and cell density, a linear (LIN) 
and a sigmoid (SIGMOID) relation; each of the relations were 
used either in the index tumour or for the whole prostate 
(Table 1). The linear relation was derived from the results of 
Gibbs et al. 2009 while the SIGMOID relation modulated the 
cell density between two constant values, 1.9·105 cell/cm3 
(Walsh and van der Putten 2013) and 107 cell/cm3 (Søvik et 
al. 2007). TCP calculations were also performed using these 
two uniform densities for the whole prostate tissue. All TCP 
calculations were performed assuming an α/β = 1.93 Gy from 
a recent meta-analysis (Vogelius and Bentzen 2013) and α = 
0.18 Gy-1 (consistent with clinical outcomes in the same 
meta-analysis).  
Results:  
 
Overall, TCP curves based on ADC maps showed larger 
differences between individuals than those assuming a 
uniform cell density. Using the SIGMOID relation for the index 
lesion, the range of D50% (the dose required to reach 50% 
TCP) was 9.6 Gy, compared to 5.3 Gy using a constant density 
for the entire prostate of 107 cells/cm3 (Fig. 1). The TCP 
curves found using the SIGMOID relation for the whole 
prostate were very close to those found using a constant cell 
density of 107 cells/cm3. The two linear approaches gave 
lower TCP values (for the same dose) than either of these 
approaches.  
Conclusions: This study has showed how ADC maps can be 
used to estimate voxel cell density to allow for an 
individualised TCP model for use in RT of prostate cancer. 
The individualised, voxel-based cell density distributions 
resulted in TCP curves with a larger range in D50% compared 
with the TCP models based on uniform cell density 
distributions.  
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Purpose/Objective: Gastrointestinal (GI) toxicity following 
radiotherapy (RT) for prostate cancer involves the interplay 
between various GI tract structures and symptoms. The 
purpose of this study was to further improve our 
understanding of the wider range of GI toxicity by studying 
the relationship between dose to various segments of the GI 
tract and patient-reported outcomes in four previously 
identified symptom groups, labelled Leakage, Mucous, Pain, 
and Urgency. 
Materials and Methods: The three cohorts investigated in 
this study were previously treated for localized prostate 
cancer with primary or salvage external beam RT (EBRT or 
POSTOP) at two centres in 1993-2007 (N=681; time to follow-
up: 1-14 years; average age at RT: 64-70 years). Prescribed 
dose was 70-78 Gy in 2Gy fractions. Relationships between 
maximum or mean absorbed dose (Dmax or Dmean) to the most 
caudal 4 cm of the sigmoid colon (SC), the rectum (R), the 
anal sphincter region (AS), or combinations thereof (SC+R, 
SC+AS, R+AS, SC+R+AS), and single/joint symptoms in the 
previously identified symptom groups were investigated using 
logistic regression and the area under the receiver operating 
curve (Az). The symptom groups were based on factor 
analysis results (59 symptoms in total, two centre-specific 
questionnaires (Q1 and Q2))[1]. 
 
[1] XX, et al. Identifying groups of patient-reported 
gastrointestinal symptoms using factor analysis, XX 2014. 
 
Results: Among the statistically significant relationships 
identified between dose to single/joint structures and 
symptoms (p≤0.05; Fig.1.), Leakage was best predicted by AS 
Dmean, or AS+R and AS+R+SC Dmax (Az=0.68-0.73), and Mucous 
by AS Dmax (Az=0.67) or Dmean (Az=0.62). Pain was best 
predicted by AS and AS+SC Dmax (Az=0.69), or AS+R, R+SC, and 
AS+R+SC Dmean (Az=0.62) whereas Urgency was best predicted 
by AS and R Dmean (Az=0.58-0.78), or R and R+SC Dmax (Az=0.62).  
 
 
Conclusions: Our patient-reported outcome-based findings 
suggest that the anal sphincter, alone or in combination with 
other segments of the GI tract, is a key structure for a 
majority of the investigated GI symptoms. Sparing of the anal 
sphincter region, as defined separately from the rectum, has 
the potential to further reduce GI toxicity and increase the 
overall quality of life following RT for prostate cancer.  
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Purpose/Objective: Tumor control probability (TCP) model 
parameters for NSCLC have been only obtained from outcome 
data of conventionally or SBRT regiments thus far. Moreover, 
TCP model parameters in the literature were typically 
derived using the CTV prescription dose or dose-volume 
histograms (DVHs) which do not reflect the presence of 
geometric uncertainties, especially in SBRT where the dose 
heterogeneity is often high. In this study, GTV and PTV DVHs 
and local control data of both conventional and SBRT 
treatments were used to derive optimal TCP model 
